EMILDAP M 10MG/500MG TABLETS contain Dapagliflozin 10mg and Metformin 500mg, a combination antidiabetic medicine prescribed for type 2 diabetes management with diet and exercise.
EMILDAP M 10MG/500MG TABLETS | Dapagliflozin Metformin Guide
EMILDAP M 10MG/500MG TABLETS contain Dapagliflozin 10mg and Metformin 500mg, a combination antidiabetic medicine prescribed for type 2 diabetes management with diet and exercise.
EMILDAP M 10MG/500MG TABLETS
EMILDAP M 10MG/500MG TABLETS (DAPAGLIFLOZIN 10MG + METFORMIN 500MG): Comprehensive Guide and Benefits
Introduction to EMILDAP M 10MG/500MG TABLETS
EMILDAP M 10MG/500MG: Dual-Action Diabetes Management Therapy
EMILDAP M 10MG/500MG TABLETS contain a combination of Dapagliflozin 10mg and Metformin 500mg. It belongs to the SGLT2 inhibitor + Biguanide antidiabetic class and is prescribed for improving blood glucose control in adults with type 2 diabetes mellitus along with proper diet and exercise.
Dapagliflozin helps remove excess glucose through urine, while Metformin reduces glucose production in the liver and improves insulin sensitivity. EMILDAP M 10MG/500MG TABLETS are prescription-only medicines and should be taken under medical supervision.
Key Benefits of EMILDAP M 10MG/500MG TABLETS
Helps improve blood glucose control in adults with type 2 diabetes.
Combines two medicines with complementary glucose-lowering actions.
Supports elimination of excess glucose through the kidneys.
Helps improve insulin sensitivity.
Helps reduce the risk of diabetes-related complications when used as part of a complete diabetes management plan.
How EMILDAP M 10MG/500MG TABLETS Works
EMILDAP M contains two active ingredients:
1. Dapagliflozin 10MG
Dapagliflozin is an SGLT2 (Sodium-Glucose Cotransporter-2) inhibitor.
It works by blocking SGLT2 activity in the kidneys, reducing glucose reabsorption and allowing excess glucose to be removed through urine. This helps lower blood glucose levels without directly stimulating insulin release.
2. Metformin 500MG
Metformin belongs to the biguanide class of antidiabetic medicines.
It helps reduce glucose production by the liver, improves the body's response to insulin, and supports better glucose utilization by tissues.
Together, these medicines provide dual-action blood sugar control.
Usage Instructions for EMILDAP M 10MG/500MG TABLETS
Take EMILDAP M exactly as prescribed by your doctor.
Swallow the tablet whole with water.
Do not crush, chew, or break the tablet.
Take it with or after food unless otherwise advised.
Take it at the same time each day for consistent results.
Do not stop treatment without consulting your healthcare provider.
Regular monitoring of blood glucose and kidney function may be required.
Medicinal Advantages of EMILDAP M 10MG/500MG TABLETS
Provides combination therapy for type 2 diabetes management.
Helps maintain better glycemic control.
Supports glucose removal through kidney pathways.
Improves insulin sensitivity through Metformin action.
Reduces the need for multiple separate diabetes tablets.
Supports long-term diabetes management when combined with lifestyle modifications.
Note: EMILDAP M should be used along with a balanced diet, regular physical activity, and routine medical monitoring.
Off-Label Uses of EMILDAP M 10MG/500MG TABLETS
Dapagliflozin and Metformin combinations may be considered by specialists for additional applications based on clinical evidence and individual patient requirements.
Possible specialist-guided applications may include:
Individualized metabolic management strategies.
Cardiovascular or kidney-related treatment approaches where medically appropriate.
Disclaimer: Off-label use should only be considered under qualified medical supervision.
Expert Advice for Optimal Use
Follow the prescribed dosage schedule carefully.
Maintain adequate hydration unless fluid restriction is advised.
Monitor blood sugar levels regularly.
Inform your doctor before surgery or prolonged fasting.
Limit excessive alcohol intake.
Report symptoms such as severe weakness, dehydration, urinary discomfort, or unusual breathing difficulty.
Precautions
Kidney Function
Kidney function should be assessed before and during treatment because both Dapagliflozin and Metformin require kidney-related safety evaluation.
Blood Sugar Monitoring
When used with insulin or insulin-releasing medicines, the risk of low blood sugar may increase. Dose adjustments may be required.
Pregnancy & Breastfeeding
Consult your healthcare provider before using EMILDAP M during pregnancy or breastfeeding.
Drug Interactions
Inform your doctor if you take:
Insulin or other diabetes medicines
Diuretics (water tablets)
Blood pressure medicines
Kidney-affecting medicines
Alcohol-containing products
Existing Medical Conditions
Tell your doctor if you have:
Kidney disease
Liver disease
Frequent urinary infections
Dehydration problems
History of diabetic ketoacidosis
Storage Instructions
Store below 30°C.
Keep tablets in the original blister packaging.
Protect from moisture and direct sunlight.
Keep away from children.
Do not use after the expiry date.
Frequently Asked Questions (FAQs)
Q: What is EMILDAP M 10MG/500MG TABLETS used for?
A: EMILDAP M 10MG/500MG TABLETS are used to improve blood glucose control in adults with type 2 diabetes mellitus along with diet and exercise.
Q: What are the active ingredients in EMILDAP M 10MG/500MG?
A: The active ingredients are Dapagliflozin 10mg and Metformin 500mg.
Q: Is EMILDAP M an insulin medicine?
A: No. EMILDAP M does not contain insulin. It works through kidney glucose removal and improved insulin sensitivity.
Q: Can EMILDAP M be taken without prescription?
A: No. EMILDAP M is a prescription medicine and should be used only under medical guidance.
Q: What are common side effects of EMILDAP M?
A: Possible side effects may include diarrhea, nausea, stomach discomfort, increased urination, urinary tract infections, genital fungal infections, and dehydration.
Q: How does EMILDAP M help control diabetes?
A: Dapagliflozin removes excess glucose through urine, while Metformin reduces glucose production in the liver and improves insulin sensitivity, helping achieve better blood sugar control.
Product Tags
EMILDAP M 10MG/500MG TABLETS, Dapagliflozin 10mg Metformin 500mg, Dapagliflozin Metformin Tablet, SGLT2 Inhibitor Medicine, Biguanide Antidiabetic Medicine, Type 2 Diabetes Tablet, Blood Sugar Control Medicine, Diabetes Combination Therapy, Oral Diabetes Medication, Prescription Diabetes Tablet, Glucose Lowering Medicine, Kidney Support Diabetes Therapy, EMILDAP M Tablet, Emcure Pharmaceuticals Diabetes Medicine.
Happy Customer
Satnam Pharmaceuticals is a trusted medicine supply company committed to delivering high-quality healthcare products to pharmacies, hospitals, clinics, and healthcare providers. We offer a wide range of pharmaceutical medicines and healthcare essentials from reliable manufacturers.
Copyright © 2026 Satnam Pharma. All Rights Reserved.